- Home
- FFIN vs LNTH Comparison
FFIN vs LNTH Comparison
Compare FFIN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIN
- LNTH
- Stock Information
- Founded
- FFIN 1890
- LNTH 1956
- Country
- FFIN United States
- LNTH United States
- Employees
- FFIN N/A
- LNTH N/A
- Industry
- FFIN Major Banks
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FFIN Finance
- LNTH Health Care
- Exchange
- FFIN Nasdaq
- LNTH Nasdaq
- Market Cap
- FFIN 5.8B
- LNTH 6.3B
- IPO Year
- FFIN N/A
- LNTH 2015
- Fundamental
- Price
- FFIN $36.05
- LNTH $93.82
- Analyst Decision
- FFIN Hold
- LNTH Strong Buy
- Analyst Count
- FFIN 4
- LNTH 6
- Target Price
- FFIN $38.75
- LNTH $132.67
- AVG Volume (30 Days)
- FFIN 518.0K
- LNTH 799.5K
- Earning Date
- FFIN 01-23-2025
- LNTH 02-20-2025
- Dividend Yield
- FFIN 1.97%
- LNTH N/A
- EPS Growth
- FFIN N/A
- LNTH 304.57
- EPS
- FFIN 1.45
- LNTH 6.02
- Revenue
- FFIN $510,305,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- FFIN N/A
- LNTH $19.64
- Revenue Next Year
- FFIN $6.83
- LNTH $4.38
- P/E Ratio
- FFIN $25.27
- LNTH $15.42
- Revenue Growth
- FFIN 4.11
- LNTH 24.15
- 52 Week Low
- FFIN $27.06
- LNTH $50.20
- 52 Week High
- FFIN $44.66
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- FFIN 35.77
- LNTH 55.67
- Support Level
- FFIN $35.14
- LNTH $87.24
- Resistance Level
- FFIN $36.72
- LNTH $93.29
- Average True Range (ATR)
- FFIN 1.24
- LNTH 2.93
- MACD
- FFIN -0.19
- LNTH 0.27
- Stochastic Oscillator
- FFIN 15.61
- LNTH 71.37
About FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.